All In Biotech

Drug Trial Radar · NCT04918186

Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer

An Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

May 3, 2022

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Canadian Cancer Trials GroupResearch network
Sponsor type
Research network
Collaborators
Cancer Research Institute, New York City; AstraZeneca; BioAtla, Inc.
First posted
Jun 8, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being done to answer the following question: What are the effects of a new drug or drugs on ovarian cancer? The pre-study screening may be done to test a sample of tissue for biomarkers to determine participation in the study.

Conditions

  • Ovarian Cancer

Interventions

  • DurvalumabDrug

    1500mg IV, 60 min day 1 every 4 weeks

  • BA3011Drug

    IV

  • BA3021Drug

    IV

  • ENB003Drug

    IV

  • ToripalimabDrug

    IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To efficiently identify based on objective response rate (ORR), by investigator assessment using RECIST 1.1, promising immunotherapy combinations for the treatment of high grade serous ovarian cancer for later validation in randomized trialsTime frame: 36 months

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • The University of Chicago Medical Center

    Chicago, Illinois · Recruiting

  • BCCA - Kelowna

    Kelowna, British Columbia, Canada · Not yet recruiting

  • BCCA - Vancouver

    Vancouver, British Columbia, Canada · Not yet recruiting

  • Odette Cancer Centre

    Toronto, Ontario, Canada · Not yet recruiting

  • University Health Network

    Toronto, Ontario, Canada · Not yet recruiting

  • CHUM-Centre Hospitalier de l'Universite de Montreal

    Montreal, Quebec, Canada · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.